The New Role of SGLT2 Inhibitors in the Management of Heart Failure: Current Evidence and Future Perspective

• Main Authors: Saverio Muscoli (Author), Francesco Barillà (Author), Rojin Tajmir (Author), Marco Meloni (Author), David Della Morte (Author), Alfonso Bellia (Author), Nicola Di Daniele (Author), Davide Lauro (Author), Aikaterini Andreadi (Author)
• Format: Book
• Published: MDPI AG, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The sodium-glucose transporter 2 inhibitors (SGLT2i) are a relatively new class of medication used in the management of type 2 diabetes. Recent clinical trials and research have demonstrated this class's effectiveness in treating heart failure, since they reduce the risk of cardiovascular event...